Nordic Asia Life-science Summit
June 2, 2025
CEO, Martin Jönsson attended at Nordic Asia Life-science Summit on May 28th, 2025. Scan the QR-code, to read the presentation
AlzeCure participated at the 3rd Swedish Meeting for Alzheimer Research
April 10, 2025
Several from AlzeCure participated at the Swedish Meeting for Alzheimer Research, April 10, 2025, where also Dr. Cristina Parrado-Fernández, Senior Scientist present...
AlzeCure receives EU grant for Phase 2 clinical trial of NeuroRestore ACD856 for Alzheimer’s disease
February 17, 2025
“The grant we received from the European Innovation Council is a strong validation of NeuroRestore ACD856, which has a unique pharmacological mechanism that en...
AlzeCure´s CEO, Martin Jönsson and CSO, Johan Sandin attend JP Morgan in San Francisco, January 13 – 16, 2025
February 4, 2025
Read more: https://www.biocentury.com/jpm-guide
AlzeCure presents new anti-inflammatory data with NeuroRestore ACD856 at the Alzheimer’s conference CTAD
October 17, 2024
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer&#...